Discovery and optimization of 2,4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors.

Bo Chao,Xian-Kun Tong,Wei Tang,De-Wen Li,Pei-Lan He,Jean-Michel Garcia,Li-Min Zeng,An-Hui Gao,Li Yang,Jia Li,Fa-Jun Nan,Michael Jacobs,Ralf Altmeyer,Jian-Ping Zuo,You-Hong Hu
DOI: https://doi.org/10.1021/jm2015952
IF: 8.039
2012-01-01
Journal of Medicinal Chemistry
Abstract:The results of a high-throughput screening assay using the DENV-2 replicon showed that the 2,4-diaminoquinazoline derivative 4a has a high dengue virus inhibitory activity (EC50 = 0.15 mu M). A series of 2,4-diaminoquinazoline derivatives based on 4a as a lead compound were synthesized and subjected to structure-antidengue activity relationship studies. Among the series of 2,4-diaminoquinazoline derivative probed, 4o was observed to display both the highest antiviral potency (EC50 = 2.8 nM, SI > 1000) and an excellent pharmacokinetic profile.
What problem does this paper attempt to address?